Mesenchymal Stem Cells for Severe Intraventricular Hemorrhage in Preterm Infants: Phase I Dose‐Escalation Clinical Trial

We previously demonstrated that transplanting mesenchymal stem cells (MSCs) improved recovery from brain injury induced by severe intraventricular hemorrhage (IVH) in newborn rats. To assess the safety and feasibility of MSCs in preterm infants with severe IVH, we performed a phase I dose‐escalation...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, So Yoon, Chang, Yun Sil, Sung, Se In, Park, Won Soon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Human Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265626/
https://www.ncbi.nlm.nih.gov/pubmed/30133179
http://dx.doi.org/10.1002/sctm.17-0219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6265626/
https://www.ncbi.nlm.nih.gov/pubmed/30133179
http://dx.doi.org/10.1002/sctm.17-0219

Ejemplares similares